18F-FDG brain/cerebellum-to-liver ratios as prognostic factors

• by David Morland, Eric Durot

• August 27, 2025

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

Lilly moves to acquire Kelonia, plus gene therapy for deafness approved

• April 27, 2026

• 6 min

Anatomy-aware lymphoma lesion detection in whole-body PET/CT

• by Simone Bendazzoli, Antonios Tzortzakakis, Andréas Abrahamsson, Björn Engelbrekt Wahlin, Örjan Smedby, Maria Holstensson, Rodrigo Moreno

• May 22, 2026

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series

• by Sandra Susanibar-Adaniya, Benjamin A. Derman, Adam D. Cohen, Dan T. Vogl, Shambavi Richard, Adriana Rossi, Matthew J. Frigualt, Andrew J. Yee, Binod Dhakal, Noffar Bar

• April 28, 2026